Neurosciences patient information leaflets

This page lists leaflets produced or used by our department. Each leaflet is reviewed at least every three years to make sure it is kept up to date.

Home video EEG telemetry

Description
This leaflet explains more about having a home video EEG telemetry

Ketogenic diet information for families

Description
This leaflet has been given to you to help answer some of the questions you may have about the ketogenic diet as a treatment for epilepsy in children.

Lower limb movement service

Description
This leaflet gives more information on what to expect if your child is offered an appointment with the lower limb movement service.

Managing your child's drooling

Description
The information in this leaflet is aimed at supporting the discussions we had with you about your child's treatment when you attended the saliva control clinic. It gives you more information about different methods of managing your child's drooling.

Neonatal stroke

Description
This leaflet gives information for families who have been told their baby has had a stroke around the time of birth. It answers some commonly asked questions and provides an overview of neonatal stroke.

Neurofibromatosis type 1 transition

Description
This leaflet is for patients with neurofibromatosis type 1 and explains more about the transition process offered in the neurofibromatosis (NF) service.

Neurofibromatosis type 2 transition

Description
This leaflet is for patients with neurofibromatosis type 2 and explains more about the transition process offered in the neurofibromatosis (NF) service.

Neuropsychology service

Description
This leaflet provides information about what our neuropsychology service is, including how children can be referred to it and what the neuropsychology assessment involves.

Nusinersen for SMA type 1

Description
This leaflet explains more about the use of nusinersen (also called Spinraza®) as a treatment for spinal muscular atrophy (SMA).

Nusinersen for SMA type 2

Description
This leaflet explains more about the use of nusinersen (also called Spinraza®) as a treatment for spinal muscular atrophy (SMA)
Displaying 11 to 20 of 31

More patient leaflets

For an A-Z list of all our patient information leaflets, please see the parents and visitors section.
©  Guy's and St Thomas' NHS Foundation Trust.
King's Health Partners logo